Activation of EphA4 induced by EphrinA1 exacerbates disruption of the blood‑brain barrier following cerebral ischemia‑reperfusion via the Rho/ROCK signaling pathway

  • Authors:
    • Fangbin Chen
    • Zhiyang Liu
    • Wei Peng
    • Zhiqin Gao
    • Hui Ouyang
    • Tongjun Yan
    • Songbai Ding
    • Zhankui Cai
    • Bin Zhao
    • Longjin Mao
    • Zhiyong Cao
  • View Affiliations

  • Published online on: July 17, 2018     https://doi.org/10.3892/etm.2018.6460
  • Pages: 2651-2658
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Vascular dementia (VD) is a syndrome characterized by progressive cognitive decline. According to previous studies, stroke is considered to be a risk factor for VD. The disruption of the blood‑brain barrier (BBB) is pivotal to the pathology of stroke, as it contributes to post‑stroke inflammation and edema. It has been reported that the Eph/Ephrin signaling pathway serves an important role in central nervous system injury. However, the role of EphrinA1/EphA4 signaling in BBB damage following ischemic stroke has not yet been reported. Oxygen‑glucose deprivation/reperfusion was performed to detect changes in EphrinA1 and EphA4 expression in human brain microvascular endothelial cells (HBMECs). Male mice were randomly divided into four groups [Sham, ischemia‑reperfusion (I/R), I/R+EphrinA1 and I/R+EphA4] to observe the role of EphrinA1 and EphA4 under I/R conditions in vivo. The results of the present study revealed that the expression of EphrinA1 and EphA4 was significantly increased following I/R in vitro and in vivo. The administration of soluble ligand EphrinA1 enhanced CD68+ cell accumulation, brain edema and dysfunction of the BBB, with lower expression levels of zonula occludens‑1 (ZO‑1) and Claudin‑5. In addition, EphrinA1‑treated mice had a higher level of caspase‑3 and a lower level of phosphorylated‑protein kinase B. However, the effects of EphrinA1 were abolished by EphA4‑Fc, an inhibitor of EphA4. These results suggested that EphrinA1 exerted its effects on I/R injury via the activated EphA4 receptor. In addition, EphrinA1 decreased ZO‑1 and Claudin‑5 expression through the Rho/Rho associated kinase (ROCK) signaling pathway, which was attenuated by the pharmacological inhibition of Rho (C3 transferase) or ROCK (Y‑27632). In conclusion, the present study provides evidence that the activation of EphA4 induced by EphrinA1 contributes to BBB damage following ischemic stroke through the Rho/ROCK signaling pathway, which highlights a potential therapeutic strategy for ischemic stroke and may help the development of preventative interventions for VD.
View Figures
View References

Related Articles

Journal Cover

September-2018
Volume 16 Issue 3

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Chen F, Liu Z, Peng W, Gao Z, Ouyang H, Yan T, Ding S, Cai Z, Zhao B, Mao L, Mao L, et al: Activation of EphA4 induced by EphrinA1 exacerbates disruption of the blood‑brain barrier following cerebral ischemia‑reperfusion via the Rho/ROCK signaling pathway. Exp Ther Med 16: 2651-2658, 2018
APA
Chen, F., Liu, Z., Peng, W., Gao, Z., Ouyang, H., Yan, T. ... Cao, Z. (2018). Activation of EphA4 induced by EphrinA1 exacerbates disruption of the blood‑brain barrier following cerebral ischemia‑reperfusion via the Rho/ROCK signaling pathway. Experimental and Therapeutic Medicine, 16, 2651-2658. https://doi.org/10.3892/etm.2018.6460
MLA
Chen, F., Liu, Z., Peng, W., Gao, Z., Ouyang, H., Yan, T., Ding, S., Cai, Z., Zhao, B., Mao, L., Cao, Z."Activation of EphA4 induced by EphrinA1 exacerbates disruption of the blood‑brain barrier following cerebral ischemia‑reperfusion via the Rho/ROCK signaling pathway". Experimental and Therapeutic Medicine 16.3 (2018): 2651-2658.
Chicago
Chen, F., Liu, Z., Peng, W., Gao, Z., Ouyang, H., Yan, T., Ding, S., Cai, Z., Zhao, B., Mao, L., Cao, Z."Activation of EphA4 induced by EphrinA1 exacerbates disruption of the blood‑brain barrier following cerebral ischemia‑reperfusion via the Rho/ROCK signaling pathway". Experimental and Therapeutic Medicine 16, no. 3 (2018): 2651-2658. https://doi.org/10.3892/etm.2018.6460